KEY FINDINGS
The Asia Pacific immunosuppressant drugs market is projected to register a CAGR of 5.51% during the forecast period, 2019-2028. The rising per capita income in several countries of the region, government initiatives for the enhancement of the healthcare sector, the presence of leading manufacturers, and their activities for extending geographical presence, are the most important factors driving the market growth.
MARKET INSIGHTS
The Asia Pacific immunosuppressant drugs market growth analysis encompasses the market evaluation of Japan, Indonesia, China, Thailand, Vietnam, India, Australia & New Zealand, South Korea, and the rest of Asia Pacific. There is a growing demand for organ translation, and a rise in autoimmune diseases like irritable bowel syndrome and arthritis, which impacts market growth in the region. In Japan, the drugs for immunosuppressive agents and diabetes are registering strong growth, and is set to witness more growth propelled by novel biologics. India has placed itself in a prominent position in global pharmaceuticals. It is a major contributor to generic medicines globally, ranking third in the world for production by volume. The country accounts for almost 15% of the world's production by value. The country houses more than 3000 pharma companies, along with being home to several autoimmune diseases. India has an emboldened living kidney transplantation program, second to the USA. Such factors make the country a conducive market in terms of growth prospects.
COMPETITIVE INSIGHTS
Some of the well-established companies of the market include, Sanofi SA, Dr. Reddy's Laboratories Ltd, Cipla Ltd, Pfizer Inc, Mylan NV, Novartis International Ag (Sandoz), etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation cater to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Asia Pacific Immunosuppressant Drugs Market Forecast 2019-2028
Table of Contents
1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Development Of Immunosuppressant Drugs
3.2. Market Definition
3.3. Key Drivers
3.3.1. Increase In The Number Of Autoimmune Disorders
3.3.2. Rise In Organ Transplantation
3.3.3. Growth In The Pharmaceutical Industry
3.4. Key Restraints
3.4.1. Side Effects Of Immunosuppressant Drugs
3.4.2. Lack Of Awareness About Organ Donation
4. Key Analytics
4.1. Key Investment Insights
4.2. Porter's Five Force Analysis
4.2.1. Buyer Power
4.2.2. Supplier Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Opportunity Matrix
4.4. Vendor Landscape
5. Market By Distribution Channel
5.1. Hospital Pharmacies
5.2. Retail Pharmacies
5.3. Online Pharmacies
6. Market By End-User
6.1. Organ Transplantation
6.2. Autoimmune Disorders
6.3. Others
7. Market By Drug Class
7.1. Corticosteroids
7.2. Monoclonal Antibodies
7.3. Calcineurin Inhibitors
7.4. Mtor Inhibitors
7.5. Others
8. Geographical Analysis
8.1. Asia Pacific
8.1.1. China
8.1.2. Japan
8.1.3. India
8.1.4. South Korea
8.1.5. Indonesia
8.1.6. Thailand
8.1.7. Vietnam
8.1.8. Australia & New Zealand
8.1.9. Rest Of Asia Pacific
9. Company Profiles
9.1. Abbvie Inc
9.2. Allergan Plc (Acquired By Abvie Inc)
9.3. Astellas Pharma Inc
9.4. Bristol-Myers Squibb Company
9.5. Cipla Ltd
9.6. Dr. Reddy's Laboratories Ltd
9.7. F Hoffmann-La Roche Ag
9.8. Glaxosmithkline Plc
9.9. Intas Pharmaceuticals Ltd (Accord Healthcare Ltd)
9.10. Janssen Pharmaceuticals Nv (Jhonson & Jhonson)
9.11. Mylan Nv
9.12. Novartis International Ag (Sandoz)
9.13. Pfizer Inc
9.14. Sanofi Sa
9.15. Veloxis Pharmaceuticals
List of Tables
Table 1: Market Snapshot - Immunosuppressant Drugs
Table 2: Side Effects Of Immunosuppressant Drugs
Table 3: Top 15 Positive Net Exports Countries And Negative Net Exports For Drugs & Medicines Countries
Table 4: Asia Pacific Immunosuppressant Drugs Market, By Distribution Channel, Historical Years, 2016-2019 (In $ Million)
Table 5: Asia Pacific Immunosuppressant Drugs Market, By Distribution Channel, Forecast Years, 2019-2028 (In $ Million)
Table 6: Asia Pacific Immunosuppressant Drugs Market, By End-User, Historical Years, 2016-2019 (In $ Million)
Table 7: Asia Pacific Immunosuppressant Drugs Market, By End-User, Forecast Years, 2019-2028 (In $ Million)
Table 8: Asia Pacific Immunosuppressant Drugs Market, By Class, Historical Years, 2016-2019 (In $ Million)
Table 9: Asia Pacific Immunosuppressant Drugs Market, By Class, Forecast Years, 2019-2028 (In $ Million)
Table 10: Asia Pacific Immunosuppressant Drugs Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 11: Asia Pacific Immunosuppressant Drugs Market, By Country, Forecast Years, 2019-2028 (In $ Million)
List of Figures
Figure 1: Development Of Immunosuppressant Drugs
Figure 2: Key Investment Insights
Figure 3: Porter's Five Force Analysis
Figure 4: Opportunity Matrix
Figure 5: Vendor Landscape
Figure 6: Asia Pacific Immunosuppressant Drugs Market, Growth Potential, By Distribution Channel, In 2019
Figure 7: Asia Pacific Immunosuppressant Drugs Market, By Hospital Pharmacies, 2019-2028 (In $ Million)
Figure 8: Asia Pacific Immunosuppressant Drugs Market, By Retail Pharmacies, 2019-2028 (In $ Million)
Figure 9: Asia Pacific Immunosuppressant Drugs Market, By Online Pharmacies, 2019-2028 (In $ Million)
Figure 10: Asia Pacific Immunosuppressant Drugs Market, Growth Potential, By End-User, In 2019
Figure 11: Asia Pacific Immunosuppressant Drugs Market, By Organ Transplantation, 2019-2028 (In $ Million)
Figure 12: Asia Pacific Immunosuppressant Drugs Market, By Autoimmune Disorders, 2019-2028 (In $ Million)
Figure 13: Asia Pacific Immunosuppressant Drugs Market, By Others, 2019-2028 (In $ Million)
Figure 14: Asia Pacific Immunosuppressant Drugs Market, Growth Potential, By Class, In 2019
Figure 15: Asia Pacific Immunosuppressant Drugs Market, By Corticosteroids, 2019-2028 (In $ Million)
Figure 16: Asia Pacific Immunosuppressant Drugs Market, By Monoclonal Antibodies, 2019-2028 (In $ Million)
Figure 17: Asia Pacific Immunosuppressant Drugs Market, By Calcineurin Inhibitors, 2019-2028 (In $ Million)
Figure 18: Asia Pacific Immunosuppressant Drugs Market, By Mtor Inhibitors, 2019-2028 (In $ Million)
Figure 19: Asia Pacific Immunosuppressant Drugs Market, By Others, 2019-2028 (In $ Million)
Figure 20: Asia Pacific Immunosuppressant Drugs Market, Regional Outlook, 2019 & 2028 (In %)
Figure 21: China Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 22: Japan Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 23: India Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 24: South Korea Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 25: Indonesia Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 26: Thailand Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 27: Vietnam Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 28: Australia & New Zealand Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 29: Rest Of Asia Pacific Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
